This photo shows the outside of a Charleston, S.C., condominium belonging to Eugene Zurlo on Monday, Oct. 19, 2020. The Trump administration recently gave the longtime Republican political donor seed money to test a possible COVID-19-fighting blood plasma technology, noting Zurlo’s “manufacturing facilities” in Charleston. An AP investigation found no manufacturing facilities. The company operates out of Zurlo’s condo. He and his partners may now be in line for as much as $65 million in taxpayer money. (AP Photo/Meg Kinnard) (Photo: Meg Kinnard, AP)

WASHINGTON — An obscure South Carolina company may be in line for millions of dollars in U.S. government funding to produce a coronavirus treatment after a former Republican senator with a financial stake in the business lobbied senior U.S. government officials.

Plasma Technologies LLC, has received seed money to test a possible COVID-19-fighting blood plasma technology. But as much as $65 million more could be on